PetMed Express Inc (PETS) stock
Close on Nov 11, 2026Market cap $23.09MP/E –Yield 0.00%
PetMed Express Inc saw revenue fall 19.2% to $160.26M over the twelve months to Sep 30, 2026. Free cash flow was -$24.62M. At the latest close the market valued the company at $23.09M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $23.09M
- P/E ratio
- –
- Price to sales
- 0.14
- Price to book
- 1.37
- Dividend yield
- 0.00%
- Free cash flow yield
- -106.63%
Fundamentals
- Revenue
- $160.26M
- Net income
- -$27.19M
- EPS, diluted
- -$1.28
- Free cash flow
- -$24.62M
- Book value per share
- $0.80
- Diluted shares
- 21M
Trading
- Previous close
- $1.21
- Open
- $1.20
- Day's range
- $1.06 – $1.23
- Volume
- 403,933
- Average volume (20 days)
- 100,123
- Beta (5 years)
- 0.85
- 52-week range
- $1.06 – $4.10
- RSI (14 days)
- 27.7
- Volatility (1 year)
- 97.0%
- Relative volume
- 3.60×
- WACC
- 9.1%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | PETS | S&P 500 | Difference | PETS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.1% | -2.4% | −14.7 pts | ||
| 3 months | -46.2% | -1.2% | −45.1 pts | ||
| Year to date | -66.7% | +12.3% | −79.0 pts | ||
| 1 year | -60.4% | +12.4% | −72.9 pts | ||
| 3 years | -85.2% | +78.8% | −164.0 pts | -47.1% | +21.4% |
| 5 years | -96.0% | +75.2% | −171.1 pts | -47.4% | +11.9% |
| 10 years | -93.3% | +311.1% | −404.4 pts | -23.7% | +15.2% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases PetMed Express filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Update
- Results
About PetMed Express
Retail-Drug Stores and Proprietary Stores
PetMed Express, Inc. operates as a direct-to-consumer pet health and wellness retailer and online pharmacy. The company provides prescription medications, generic pharmaceuticals, compounded prescriptions, and over-the-counter health and wellness supplies for cats, dogs, and horses. Its catalog also includes specialized prescription diets, non-prescription pet food, treats, supplements, and related care merchandise. Through owned digital retail channels and customer contact centers, the business serves retail pet owners nationwide, while coordinating prescription authorizations directly with licensed veterinarians.
Company profile, executives and historyPetMed Express stock: common questions
What is PetMed Express's stock price?
PETS closed at $1.06 on Nov 11, 2026, down 11.98% on the day. Over the past 52 weeks it traded between $1.06 and $4.10.
What is PetMed Express's market cap?
PetMed Express was worth $23.09M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is PETS's P/E ratio?
PetMed Express lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.28), so it has no meaningful P/E ratio.
How much revenue does PetMed Express make?
PetMed Express reported revenue of $160.26M for the twelve months to Sep 30, 2026, down 19.2% from a year earlier.
Does PetMed Express pay a dividend?
No. PetMed Express has not paid a cash dividend over the last twelve months.
How has PETS stock performed over the past year?
Including dividends, PETS returned -60.4% over the past year, against +12.4% for the S&P 500.
How many PETS shares are sold short?
1M shares were sold short at the latest FINRA report, 5.69% of the float, or 9.1 days of average trading volume.
Who are PetMed Express's competitors?
Companies most similar to PetMed Express by business, industry and size include RDGT, GROV, GRDN, BARK, JWEL.
See a number that looks wrong?